Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats-Reference-Cited by-同舟云学术

Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats

Published:2018-04-20 Issue:4 Volume:13 Page:e0195047
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Alencar Allan K.,Carvalho Fábio I.,Silva Ananssa M.,Martinez Sabrina T.,Calasans-Maia Jorge A.,Fraga Carlos M.,Barreiro Eliezer J.,Zapata-Sudo Gisele,Sudo Roberto T.^ORCID

Funder

Instituto Nacional de Ciência e Tecnologia (INCT-INOFAR)

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq)

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Updated clinical classification of pulmonary hypertension;G Simonneau;Journal of the American College of Cardiology,2013

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);N Galie;The European respiratory journal,2015

3. Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis;AC Lajoie;The Lancet Respiratory medicine,2016

4. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension;VV McLaughlin;American journal of respiratory and critical care medicine,2006

5. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial;VV McLaughlin;Journal of the American College of Cardiology,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A peripheral system disease—Pulmonary hypertension;Biomedicine & Pharmacotherapy;2024-06

2. Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca²⁺ signaling;Physiological Reviews;2023-07-01

3. Purinoceptor: a novel target for hypertension;Purinergic Signalling;2022-02-18

4. Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction;Frontiers in Pharmacology;2021-08-20

5. Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats;Cells;2020-09-18